pharmaphorum

SEPTEMBER 18, 2024

Organon has agreed a $1.2bn deal to buy dermatology specialist Dermavant and its psoriasis therapy Vtama, under FDA review for atopic dermatitis

Dermatology 109

Dermatology 109

Fierce Pharma

DECEMBER 15, 2023

About a year after Arcutis Biotherapeutics unveiled positive data on roflumilast foam at the European Academy of Dermatology and Venereology congress 2022, the company has clinched a second FDA OK.

Dermatology 130

Dermatology 130

pharmaphorum

AUGUST 23, 2023

Leo builds dermatology pipeline with Timber deal Phil.Taylor Wed, 23/08/2023 - 08:40 Bookmark this

Dermatology 98

Dermatology 98

Pharma Mirror

APRIL 8, 2022

BARCELONA, Spain and Dundee, UK, a global biopharmaceutical company focused on skin health, today announced a research collaboration with the University of Dundee, a top-ranked university in the UK in biological sciences, to develop a novel approach against chronic and debilitating dermatology diseases where itch, or pruritus, plays a dominant role.

Dermatology 130

Dermatology Development Research 130

Bio Pharma Dive

SEPTEMBER 18, 2024

The deal hands Organon a psoriasis and eczema cream called Vtama, while Roivant will get more cash to fund its R&D plans.

Dermatology 147

Dermatology 147

pharmaphorum

NOVEMBER 11, 2021

KNUTSFORD, United Kingdom — Fishawack Health welcomes FIDE, an independent organization providing its clients with insight from clinical key opinion leaders in inflammatory dermatology. Kenneth B Gordon, MD, Professor and Chair of Dermatology at the Medical College of Wisconsin. November 10, 2021, UK.

Dermatology 98

Dermatology Life Science Marketing Development 98

pharmaphorum

AUGUST 11, 2023

Strong solutions for increasing dermatology research diversity: Trust me, I’ve got skin in the game Mike.Hammerton Fri, 11/08/2023 - 08:00 Bookmark this

Dermatology 98

Dermatology Research 98

Pharmaceutical Technology

JULY 22, 2024

Shares in the company opened 3.9% higher buoyed by an H1 performance in line with expectations.

Dermatology 130

Dermatology 130

Pharmaceutical Technology

SEPTEMBER 19, 2024

As part of the acquisition, Organon will acquire psoriasis treatment Vtama, which could soon be approved in atopic dermatitis.

Dermatology 130

Dermatology 130

Pharmaceutical Technology

MAY 17, 2024

J&J has gained access to several bispecific antibody programmes, including the Phase I-ready asset PX128 for atopic dermatitis and asthma.

Dermatology 130

Dermatology Antibody 130

BioPharma Reporter

DECEMBER 14, 2023

UK-based Lindus Health and US-based Thirty Madison today (December 14) announced they have completed the enrolment of a trial to assess their personalized dermatology telemedicine platform, Facet.

Dermatology 83

Dermatology Trials Contract Manufacturing Manufacturing 83

Medical Xpress

JANUARY 24, 2023

A dermatology program first developed by the University of Missouri in 2015 can bring life-saving diagnoses of skin conditions to communities without adequate dermatologic care.

Dermatology 75

Dermatology Medicine Development Research 75

Pharmaceutical Technology

OCTOBER 25, 2023

The funds will go towards Phase II trials for the company’s two candidates treating seborrheic keratoses and melasma.

Dermatology 130

Dermatology Trials 130

Pharma Times

APRIL 12, 2023

The trial will monitor patients across Europe for 24 months as they are treated with tildrakizumab

Dermatology 120

Dermatology Trials 120

Pharmaceutical Technology

MARCH 14, 2024

Almirall has signed a licence agreement to gain the rights for Eloxx Pharmaceuticals’ ZKN-013 for rare dermatological disease indications.

Dermatology 147

Dermatology Licensing Licensing 147

Pharma Times

SEPTEMBER 13, 2021

The awards were presented on Thursday 9 September

Dermatology 102

Dermatology 102

Fierce Pharma

SEPTEMBER 18, 2024

With its latest acquisition, women’s health outfit Organon is bringing its dermatology business to the U.S. Organon is set to acquire Roivant’s immuno-dermatology subsidiary Dermavant for up to $1.2 with a potential blockbuster in tow. billion, the companies announced Wednesday.

Dermatology 130

Dermatology 130

Outsourcing Pharma

DECEMBER 13, 2021

The pharmaceutical company currently has several promising treatments in development for gastroenterological, dermatological, and cardiological conditions.

Cardiology 145

Cardiology Dermatology Development Regulation 145

Pharmaceutical Technology

SEPTEMBER 29, 2022

The latest takeover is anticipated to boost the presence of Torrent in the dermatology segment. Holding a presence in the cosmetic dermatology sector, Curatio’s portfolio comprises more than over 50 brands that are commercialised in India. The portfolio includes brands such as Tedibar, Atogla, Spoo, B4 Nappi and Permite.

Dermatology 147

Dermatology Cosmetics Branding Scientist 147

Pharmaceutical Technology

AUGUST 22, 2024

Leo Pharma spent $36m to acquire Timber Pharmaceuticals last year, along with its lead dermatology asset TMB-001.

Dermatology 130

Dermatology 130

Pharmaceutical Technology

MARCH 13, 2024

The dermatology-centric pharma company is likely set for one of the biggest public listings in Europe since 2022.

Dermatology 130

Dermatology Pharma Companies 130

Fierce Pharma

JUNE 20, 2024

Everybody sweats, but for the 10 million people in the U.S. living with primary axillary hyperhidrosis, sweating can take on a whole new meaning. | The med is the first new chemical entity to win FDA approval specifically to treat primary axillary hyperhidrosis, or excessive underarm sweating. It's also Botanix's first approved product.

FDA Approval 110

FDA Approval Dermatology Production 110

Pharmaceutical Technology

MAY 28, 2024

J&J has made its second dermatology deal this month, adding Numab’s bispecific antibody NM26 to its growing atopic dermatitis drug portfolio.

Antibody 130

Antibody Dermatology Drugs 130

Pharmaceutical Technology

MARCH 11, 2024

Sanofi presented the data as part of a late-breaking session at the American Academy of Dermatology (AAD) 2024 conference in San Diego, US.

Dermatology 130

Dermatology 130

Pharmaceutical Technology

APRIL 15, 2024

Learn how (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid can revolutionize dermatological treatments. Discover the groundbreaking patent by Arena Pharmaceuticals for treating atopic dermatitis with a specific compound in a standard dose.

Dermatology 130

Dermatology 130

WCG Clinical

OCTOBER 9, 2023

The dermatology market is embarking on tremendous growth and sponsors need to be ready. Over the last 12 months, dermatology-focused studies have increased by roughly 20%, with top focus areas including psoriasis, atopic dermatitis, and alopecia. This rapid growth brings new challenges. Efficiency and speed are critical.

Dermatology 59

Dermatology Trials Marketing Clinical Trials 59

XTalks

JUNE 2, 2021

In this episode, Ayesha talks about Google’s new AI-based dermatology tool designed to help people identify and research conditions of the skin, hair and nails. Read the full articles here: Google Launches AI-Based Dermatology Assist Tool. WHO Calls for Probe into SARS-CoV-2 Origins as Lab Leak Theories Intensify.

Dermatology 59

Dermatology Life Science Doctor Doctors 59

Rethinking Clinical Trials

JUNE 26, 2024

Mirza is chief resident in the Department of Dermatology at the Warren Alpert Medical School of Brown University. Fatima Mirza In this Friday’s PCT Grand Rounds, Fatima Mirza of the Warren Alpert Medical School of Brown University will present “Using ChatGPT to Facilitate Truly Informed Medical Consent.”

Dermatology 147

Dermatology Clinical Trials Clinical Trials Trials 147

pharmaphorum

OCTOBER 9, 2023

Champion Innovation at the 7th Dermatology Drug Development Summit Mike.Hammerton Mon, 09/10/2023 - 14:39 Bookmark this

Dermatology 52

Dermatology Development Drugs 52

Pharmaceutical Technology

JANUARY 19, 2023

Concert’s patent portfolio includes oral Janus kinases JAK1/2 inhibitor, deuruxolitinib, to treat Alopecia Areata, an autoimmune dermatological disease. The company also noted that the deal will strengthen its global dermatology franchise with the addition of a late-stage product in an area with significant unmet need.

Dermatology 147

Dermatology Sales Drugs Production 147

BioPharma Reporter

AUGUST 22, 2023

LEO Pharma has acquired Timber Pharmaceuticals, in a deal that will add an âattractiveâ late stage asset to its pipeline in medical dermatology, the company said.

Dermatology 52

Dermatology Regulation Marketing 52

BioPharma Reporter

FEBRUARY 13, 2024

Alys Pharmaceuticals, an immuno-dermatology focused company, has launched with $100 million financing by Medicxi and an R&D pipeline enabled by multiple platform technologies.

Dermatology 52

Dermatology Regulation Marketing 52

pharmaphorum

APRIL 29, 2022

The tool has been used to assess more than 23,000 patients and discover almost 1,500 cases of cancer, whilst reducing the number if dermatology appointments needed by more than 4,700, said the company.

Dermatology 145

Dermatology Containment Marketing Development 145

Fierce Pharma

AUGUST 13, 2024

Itching for leadership in 'therapeutic dermatology,' Galderma wins FDA nod for Nemluvio to treat prurigo nodularis kdunleavy Tue, 08/13/2024 - 10:38

Dermatology 52

Dermatology 52

Fierce Pharma

NOVEMBER 4, 2024

Dermatology drugmaker Journey Medical has trekked its Dr. Reddy’s Laboratories-partnered rosacea med across the FDA finish line as Emrosi. |

Dermatology 98

Dermatology Sales Drugs 98

Fierce Pharma

OCTOBER 25, 2024

Key drugs from Johnson & Johnson and Eli Lilly stand to bolster their respective cases in competitive dermatology markets with new data readouts.

Dermatology 121

Dermatology Trials Marketing Drugs 121

Pharma Times

MARCH 29, 2021

Initiative is aiming to support NHS patient care in rheumatology and dermatology

Dermatology 110

Dermatology 110